June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Does OCT angiography provide biomarkers of visual outcome in the treatment of exudative AMD?
Author Affiliations & Notes
  • Robert Raut
    Retinal Consultants of Arizona, Phoenix, Arizona, United States
  • Neal Palejwala
    Retinal Consultants of Arizona, Phoenix, Arizona, United States
  • Sujit Itty
    Retinal Consultants of Arizona, Phoenix, Arizona, United States
  • Mark Barakat
    Retinal Consultants of Arizona, Phoenix, Arizona, United States
  • Footnotes
    Commercial Relationships   Robert Raut, None; Neal Palejwala, None; Sujit Itty, None; Mark Barakat, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 39. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Robert Raut, Neal Palejwala, Sujit Itty, Mark Barakat; Does OCT angiography provide biomarkers of visual outcome in the treatment of exudative AMD?. Invest. Ophthalmol. Vis. Sci. 2017;58(8):39.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Optical Coherence Tomography (OCT) has provided us with imaging biomarkers, such as subretinal fluid or intra-retinal fluid, useful in predicting the visual outcome of anti-VEGF treatment for age-related macular degeneration (AMD). Can the presence or location of choroidal neovascularisation (CNV) blood flow on OCT Angiography (OCTA) provide additional insights into the visual outcome of this pathology?

Methods : Retrospective study of OCTA imaging features obtained in patients undergoing anti-VEGF treatment of CNV secondary to AMD. Patients were divided in two groups: those presenting 20/50 or better vision (n=66) and those presenting 20/60 or worse vision (n=25), following more than 12 months of treatment. Each patient contributed one eye to the study. A two-tailed z-score for two independent population proportions was used to compare the incidence of each imaging feature between groups.

Results : CNV flow on OCTA, while present in the majority of patients was not significantly more so in those with poor vision (92%) than in those with good vision (83%, p=0.276). Among the patients presenting CNV flow on OCTA, the proportion of those with fovea-sparing flow was not statistically different between patients with poor vision (26%) and those with good vision (38%, p=0.308). On structural OCT, pigment epithelial detachment and subretinal fluid were equally present in patients with good vision and those with poor vision. Intra-retinal fluid and outer retinal atrophy were more prevalent in patients with poor vision (60% and 84% respectively) than in those with good vision (33%, p=0.019 and 50%, p=0.003 respectively).

Conclusions : The presence of intra-retinal fluid and outer retinal atrophy was associated with poor vision. CNV blood flow was evidenced on OCTA in most patients with exudative AMD. The location and presence of CNV however were not associated with better or worse visual outcome of treatment.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×